These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

297 related articles for article (PubMed ID: 16126936)

  • 1. Acetazolamide: a treatment for chronic mountain sickness.
    Richalet JP; Rivera M; Bouchet P; Chirinos E; Onnen I; Petitjean O; Bienvenu A; Lasne F; Moutereau S; León-Velarde F
    Am J Respir Crit Care Med; 2005 Dec; 172(11):1427-33. PubMed ID: 16126936
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Acetazolamide for Monge's disease: efficiency and tolerance of 6-month treatment.
    Richalet JP; Rivera-Ch M; Maignan M; Privat C; Pham I; Macarlupu JL; Petitjean O; León-Velarde F
    Am J Respir Crit Care Med; 2008 Jun; 177(12):1370-6. PubMed ID: 18388356
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Acetazolamide and N-acetylcysteine in the treatment of chronic mountain sickness (Monge's disease).
    Sharma S; Gralla J; Ordonez JG; Hurtado ME; Swenson ER; Schoene RB; Kelly JP; Callacondo D; Rivard C; Roncal-Jimenez C; Sirota J; Fuquay R; Jackson BP; Swenson KE; Johnson RJ; Hurtado A; Escudero E
    Respir Physiol Neurobiol; 2017 Dec; 246():1-8. PubMed ID: 28720395
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cerebral oxygenation in patients with OSA: effects of hypoxia at altitude and impact of acetazolamide.
    Ulrich S; Nussbaumer-Ochsner Y; Vasic I; Hasler E; Latshang TD; Kohler M; Muehlemann T; Wolf M; Bloch KE
    Chest; 2014 Aug; 146(2):299-308. PubMed ID: 24811331
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Patients with obstructive sleep apnea syndrome benefit from acetazolamide during an altitude sojourn: a randomized, placebo-controlled, double-blind trial.
    Nussbaumer-Ochsner Y; Latshang TD; Ulrich S; Kohler M; Thurnheer R; Bloch KE
    Chest; 2012 Jan; 141(1):131-138. PubMed ID: 21659435
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mechanisms of action of acetazolamide in the prophylaxis and treatment of acute mountain sickness.
    Leaf DE; Goldfarb DS
    J Appl Physiol (1985); 2007 Apr; 102(4):1313-22. PubMed ID: 17023566
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ginkgo biloba decreases acute mountain sickness in people ascending to high altitude at Ollagüe (3696 m) in northern Chile.
    Moraga FA; Flores A; Serra J; Esnaola C; Barriento C
    Wilderness Environ Med; 2007; 18(4):251-7. PubMed ID: 18076292
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acetazolamide 125 mg BD is not significantly different from 375 mg BD in the prevention of acute mountain sickness: the prophylactic acetazolamide dosage comparison for efficacy (PACE) trial.
    Basnyat B; Gertsch JH; Holck PS; Johnson EW; Luks AM; Donham BP; Fleischman RJ; Gowder DW; Hawksworth JS; Jensen BT; Kleiman RJ; Loveridge AH; Lundeen EB; Newman SL; Noboa JA; Miegs DP; O'Beirne KA; Philpot KB; Schultz MN; Valente MC; Wiebers MR; Swenson ER
    High Alt Med Biol; 2006; 7(1):17-27. PubMed ID: 16544963
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of acetazolamide and autoCPAP therapy on breathing disturbances among patients with obstructive sleep apnea syndrome who travel to altitude: a randomized controlled trial.
    Latshang TD; Nussbaumer-Ochsner Y; Henn RM; Ulrich S; Lo Cascio CM; Ledergerber B; Kohler M; Bloch KE
    JAMA; 2012 Dec; 308(22):2390-8. PubMed ID: 23232895
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy of low-dose acetazolamide (125 mg BID) for the prophylaxis of acute mountain sickness: a prospective, double-blind, randomized, placebo-controlled trial.
    Basnyat B; Gertsch JH; Johnson EW; Castro-Marin F; Inoue Y; Yeh C
    High Alt Med Biol; 2003; 4(1):45-52. PubMed ID: 12713711
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A dose-response study of acetazolamide for acute mountain sickness prophylaxis in vacationing tourists at 12,000 feet (3630 m).
    Carlsten C; Swenson ER; Ruoss S
    High Alt Med Biol; 2004; 5(1):33-9. PubMed ID: 15072715
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ginkgo biloba and acetazolamide prophylaxis for acute mountain sickness: a randomized, placebo-controlled trial.
    Chow T; Browne V; Heileson HL; Wallace D; Anholm J; Green SM
    Arch Intern Med; 2005 Feb; 165(3):296-301. PubMed ID: 15710792
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum immunoreactive erythropoietin in high altitude natives with and without excessive erythrocytosis.
    León-Velarde F; Monge CC; Vidal A; Carcagno M; Criscuolo M; Bozzini CE
    Exp Hematol; 1991 May; 19(4):257-60. PubMed ID: 2055289
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of acetazolamide on leg endurance exercise at sea level and simulated altitude.
    Fulco CS; Muza SR; Ditzler D; Lammi E; Lewis SF; Cymerman A
    Clin Sci (Lond); 2006 Jun; 110(6):683-92. PubMed ID: 16499476
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Exercise limitation of acetazolamide at altitude (3459 m).
    Bradwell AR; Myers SD; Beazley M; Ashdown K; Harris NG; Bradwell SB; Goodhart J; Imray CH; Wimalasena Y; Edsell ME; Pattinson KT; Wright AD; Harris SJ;
    Wilderness Environ Med; 2014 Sep; 25(3):272-7. PubMed ID: 24931587
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of chronic mountain sickness: critical reappraisal of an old problem.
    Rivera-Ch M; León-Velarde F; Huicho L
    Respir Physiol Neurobiol; 2007 Sep; 158(2-3):251-65. PubMed ID: 17580125
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Randomised, double blind, placebo controlled comparison of ginkgo biloba and acetazolamide for prevention of acute mountain sickness among Himalayan trekkers: the prevention of high altitude illness trial (PHAIT).
    Gertsch JH; Basnyat B; Johnson EW; Onopa J; Holck PS
    BMJ; 2004 Apr; 328(7443):797. PubMed ID: 15070635
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prophylactic low-dose acetazolamide reduces the incidence and severity of acute mountain sickness.
    van Patot MC; Leadbetter G; Keyes LE; Maakestad KM; Olson S; Hackett PH
    High Alt Med Biol; 2008; 9(4):289-93. PubMed ID: 19115912
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Plasma soluble erythropoietin receptor is decreased during sleep in Andean highlanders with Chronic Mountain Sickness.
    Villafuerte FC; Corante N; Anza-Ramírez C; Figueroa-Mujíca R; Vizcardo-Galindo G; Mercado A; Macarlupú JL; León-Velarde F
    J Appl Physiol (1985); 2016 Jul; 121(1):53-8. PubMed ID: 27125843
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acetazolamide improves cerebral oxygenation during exercise at high altitude.
    Vuyk J; Van Den Bos J; Terhell K; De Bos R; Vletter A; Valk P; Van Beuzekom M; Van Kleef J; Dahan A
    High Alt Med Biol; 2006; 7(4):290-301. PubMed ID: 17173514
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.